|Bid||8.88 x 1300|
|Ask||11.00 x 1000|
|Day's Range||9.32 - 9.60|
|52 Week Range||7.41 - 14.65|
|PE Ratio (TTM)||9.10|
|Earnings Date||Oct 30, 2018 - Nov 5, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.25|
NEW YORK, Aug. 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spire ...
Investor confidence was further discouraged by Cross Country Healthcare’s third quarter guidance, which predicted revenue falling 10 to 15 percent, year-over-year, and earnings per share also dropping considerably. In an investor conference call on Aug. 2, Grubbs said the company was “surprised on revenue” when existing customers pulled back on spending by $34 million in the second quarter.
The company has elected a new independent director, hoping to grow its business, but investors are selling after a disappointing second quarter.
Cross Country (CCRN) delivered earnings and revenue surprises of -16.67% and -2.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Boca Raton, Florida-based company said it had profit of 4 cents per share. Earnings, adjusted for one-time gains and costs, came to 5 cents per share. The results fell short of Wall Street expectations. ...
Cross Country Healthcare, Inc. today announced financial results for its second quarter ended June 30, 2018.
BOCA RATON, Fla. , Aug. 1, 2018 /PRNewswire/ -- Cross Country Healthcare, Inc. (the "Company") (NASDAQ: CCRN) is pleased to announce that Darrell S. Freeman Sr. , 53, was elected to serve as ...
BOCA RATON, Fla. , July 3, 2018 /PRNewswire/ -- Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its second quarter 2018 financial results on Wednesday, ...
In this article I am going to calculate the intrinsic value of Cross Country Healthcare Inc (NASDAQ:CCRN) by taking the expected future cash flows and discounting them to today’s value.Read More...
BOCA RATON, Fla. , June 14, 2018 /PRNewswire/ -- Cross Country Healthcare, Inc., (CCH) (NASDAQ: CCRN) a nationally recognized leader in Managed Services Program (MSP), is honored to be named to HRO Today's ...
Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. The new investments were disclosed in Engaged Capital's first-quarter 2018 13F securities filing, which is based on positions the activist fund held as of March 30.
BOCA RATON, Fla. (AP) _ Cross Country Healthcare Inc. (CCRN) on Wednesday reported first-quarter net income of $1.6 million, after reporting a loss in the same period a year earlier. On a per-share basis, the Boca Raton, Florida-based company said it had net income of 5 cents. The results topped Wall Street expectations.
Cross Country Healthcare, Inc. today announced financial results for its first quarter ended March 31, 2018.
BOCA RATON, Fla. , May 1, 2018 /PRNewswire/ -- Cross Country Healthcare, Inc. (Nasdaq: CCRN) announced today that it is scheduled to present at two upcoming conferences: The UBS Global Healthcare Conference ...
ST. LOUIS , April 10, 2018 /PRNewswire/ -- Cejka Executive Search, ranked on Forbes list of America's Best Executive Recruiting Firms, is pleased to announce that Mark Madden has joined the firm as Executive ...
BOCA RATON, Fla. , April 4, 2018 /PRNewswire/ -- Cross Country Healthcare, Inc. (Nasdaq: CCRN) will hold its quarterly conference call to discuss its first quarter 2018 financial results on Thursday, May ...
Companies, such as Innoviva, trading at a market price below their true values are considered to be undervalued. Investors can determine how much a company is worth based on howRead More...
Cross Country Healthcare, Inc. (CCRN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front
Amedisys (AMED) is a healthcare services company with a focus on providing home care through three segments: home health, hospice, and personal care. Of the 11 analysts covering Amedisys in March 2018, three analysts have given the stock a “strong buy” rating. Two analysts have given the stock a “buy” rating, while six analysts have given it a “hold” rating.
Cross Country Healthcare (CCRN) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.